https://www.polity.org.za
Deepening Democracy through Access to Information
Home / News / All News RSS ← Back
Africa|Health|Safety|Products
Africa|Health|Safety|Products
africa|health|safety|products
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

Covid-19: More than 2 000 healthcare workers have had Johnson & Johnson jab so far

Close

Embed Video

Covid-19: More than 2 000 healthcare workers have had Johnson & Johnson jab so far

Nurse Zoliswa Gidi-Dyosi
Nurse Zoliswa Gidi-Dyosi

19th February 2021

By: News24Wire

SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

A total of 2 260 healthcare workers received the Johnson & Johnson vaccination by Thursday night, according to the Ministry of Health.

The single-dose vaccine being used in the Sisonke (Together) protocol will be given to up to 500 000 healthcare workers, starting in 18 public sector hospitals across all nine provinces.

Advertisement

The ministry said Phase 1 of the vaccine programme was focused on health workers because they were three to four times more likely to contract Covid-19 compared to the general population.

At least 40 000 health workers have contracted the virus. More than 600 have died.

Advertisement

Phase 1 of the vaccination strategy was paused temporarily earlier in February, following concerns over the efficacy of the Oxford-AstraZeneca vaccine (also known as Covishield) against mild to moderate Covid-19 caused by the 501.V2 variant of the virus.

The health department decided that more research was needed for that vaccine.

South Africa switched to the Johnson & Johnson vaccine instead, given the urgent need to have a vaccine in place before the expected third wave of infections.

The SA Medical Research Council said the safety of the vaccine was assessed in the international Phase 3 study, "ENSEMBLE", conducted across Latin America, USA and South Africa with more than 43 000 participants.

South Africa contributed around 7 000 participants to the trial between October 2020 and February 2021, including participants who were exposed to the 501.V2 variant.

"The long-term follow-up of study participants is still ongoing, as is required for the process of regulatory approval by the South African Health Products Regulatory Authority (Sahpra) for commercial or emergency use," the SAMRC said. 

It added that, since safety and efficacy had already been proven, it was being given to healthcare workers to assess the "real world effectiveness". 

President Cyril Ramaphosa was among the first to receive this vaccine.

The programme is hoped to help mitigate the spread and severity of the virus, which was linked to another 230 deaths, according to the health ministry's report on Thursday. 

The number of new cases reported was 2 327 on Thursday.  

The cumulative number of Covid-19 cases in South Africa is 1 498 766, and the latest recovery rate is 93.6%.  

A total of 48 708 people have died.

EMAIL THIS ARTICLE      SAVE THIS ARTICLE

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options
Free daily email newsletter Register Now